![PDF) The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity PDF) The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity](https://www.researchgate.net/profile/Massimiliano-Parodi-2/publication/51124146/figure/fig1/AS:195771761729536@1423687033144/Interval-between-initiation-of-treatment-and-clinical-remission_Q320.jpg)
PDF) The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity
![PDF) Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: A prospective longitudinal study PDF) Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: A prospective longitudinal study](https://www.researchgate.net/profile/Yves-Renaudineau/publication/296636396/figure/fig1/AS:376223160127488@1466709999033/Figure1-Efficacy-of-tocilizumab-and-prednisone-on-the-polymyalgia-rheumatica-activity_Q320.jpg)
PDF) Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: A prospective longitudinal study
![PDF) The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity PDF) The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity](https://i1.rgstatic.net/publication/51124146_The_correct_prednisone_starting_dose_in_polymyalgia_rheumatica_is_related_to_body_weight_but_not_to_disease_severity/links/0c9605325cd365b008000000/largepreview.png)
PDF) The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity
![Effects of Baseline Prednisone Dose on Remission and Disease Flare in Patients with Giant Cell Arteritis Treated with Tocilizumab in a Phase 3 Randomized Controlled Trial - ACR Meeting Abstracts Effects of Baseline Prednisone Dose on Remission and Disease Flare in Patients with Giant Cell Arteritis Treated with Tocilizumab in a Phase 3 Randomized Controlled Trial - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2018/08/2751_Paper_71868_abstract_119917_0.jpg)
Effects of Baseline Prednisone Dose on Remission and Disease Flare in Patients with Giant Cell Arteritis Treated with Tocilizumab in a Phase 3 Randomized Controlled Trial - ACR Meeting Abstracts
![PDF) The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity PDF) The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity](https://www.researchgate.net/profile/Massimiliano-Parodi-2/publication/51124146/figure/tbl1/AS:669712224624644@1536683245220/of-demographic-clinical-and-laboratory-results-in-PMR-patients-with-or-without-response_Q320.jpg)
PDF) The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity
![Polymyalgia rheumatica and giant cell arteritis: management of two diseases of the elderly | Aging Health Polymyalgia rheumatica and giant cell arteritis: management of two diseases of the elderly | Aging Health](https://www.futuremedicine.com/cms/10.2217/ahe.11.50/asset/images/medium/figure1.gif)
Polymyalgia rheumatica and giant cell arteritis: management of two diseases of the elderly | Aging Health
![What is the starting dose of steroid prescribed by rheumatologist in the management of polymyalgia rheumatica? | Annals of the Rheumatic Diseases What is the starting dose of steroid prescribed by rheumatologist in the management of polymyalgia rheumatica? | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/80/8/e133/F1.large.jpg)
What is the starting dose of steroid prescribed by rheumatologist in the management of polymyalgia rheumatica? | Annals of the Rheumatic Diseases
![Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study | RMD Open Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study | RMD Open](https://rmdopen.bmj.com/content/rmdopen/3/1/e000426/F1.large.jpg?width=800&height=600&carousel=1)
Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study | RMD Open
![PDF) A case of giant cell arteritis and polymyalgia rheumatica misdiagnosed as temporomandibular dysfunction PDF) A case of giant cell arteritis and polymyalgia rheumatica misdiagnosed as temporomandibular dysfunction](https://i1.rgstatic.net/publication/323997260_A_case_of_giant_cell_arteritis_and_polymyalgia_rheumatica_misdiagnosed_as_temporomandibular_dysfunction/links/5ac3a39ba6fdcc1a5bcffbcd/largepreview.png)
PDF) A case of giant cell arteritis and polymyalgia rheumatica misdiagnosed as temporomandibular dysfunction
![The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity | BMC Musculoskeletal Disorders | Full Text The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity | BMC Musculoskeletal Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2474-12-94/MediaObjects/12891_2011_Article_1126_Fig2_HTML.jpg)